Acrivon Therapeutics
ACRV
#9672
Rank
NZ$89.25 M
Marketcap
NZ$2.83
Share price
9.15%
Change (1 day)
-69.11%
Change (1 year)

Market capitalization of Acrivon Therapeutics (ACRV)

Market cap: NZ$89.25 Million

As of March 2026 Acrivon Therapeutics has a market cap of NZ$89.25 Million. This makes Acrivon Therapeutics the world's 9672th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acrivon Therapeutics from 2022 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$89.25 M-32.86%
2025NZ$0.13 B-59.32%
2024NZ$0.32 B89.29%
2023NZ$0.17 B-54.43%
2022NZ$0.37 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of Acrivon Therapeutics was reported to be:

NZ$89.25 Million
by Nasdaq info icon info icon
NZ$89.25 Million
by CompaniesMarketCap info icon info icon